We’ll be attending the IO360 Summit! Join our Chief Executive Officer, Joanne Smith-Farrell, Ph.D. for “Engineered B-Cells” on March 25 at 4:30pm. Get all the details here: https://io360summit.com/ #IO360Summit #BeBio
关于我们
Be Bio is pioneering Engineered B Cell Medicines (BCMs) to dramatically improve the lives of patients who are living with Hemophilia B and other genetic diseases, cancer, and other serious conditions. With eyes locked on the patient, our team of purpose-driven scientists, technologists, manufacturing experts and business builders collaborate to create a bold new class of cell therapies.
- 网站
-
https://www.be.bio
Be Biopharma的外部链接
- 所属行业
- 生物技术
- 规模
- 51-200 人
- 总部
- Cambridge,Massachusetts
- 类型
- 私人持股
- 创立
- 2020
地点
-
主要
One Kendall Square
Building 200, Floor 3
US,Massachusetts,Cambridge,02139
Be Biopharma员工
动态
-
Throughout history, women in science have broken barriers, advanced knowledge, and changed the course of medicine. Their courage, brilliance, and persistence continue to reshape what’s possible for patients. At Be Bio, we put our shoulders to the wheel alongside them. Our leadership team is powered by pioneering scientists, operators, and business builders—women (and men) whose fierce dedication to our mission inspires us to develop a new class of medicines and transform patient lives. This #WomensHistoryMonth, we celebrate the women whose work has paved the way—and those who are forging new paths today. Together, we push boundaries, challenge the impossible, and build the future of medicine in service of the countless patient stories we exist to change. #WomenInLeadership #BeBio
-
Be Bio welcomes Susan Abu-Absi, Ph.D., as our new Chief Operating Officer! Dr. Abu-Absi brings 20+ years of operational and manufacturing experience in biologics and #CellAndGeneTherapy. “Susan is an outstanding leader and accomplished executive whose experience will further strengthen our leadership team as we solidify our position as a multi-program, clinical-stage company,” said Joanne Smith-Farrell, Ph.D., Chief Executive Officer. “She joins Be Bio at an ideal time, with enrollment now underway in the BeCoMe-9 trial for BE-101 in Hemophilia B, and with our development candidate, BE-102, progressing toward IND as a potential breakthrough for patients with Hypophosphatasia. We look forward to leveraging Susan’s expertise as we pioneer our B Cell Medicines to potentially transform the treatment landscape for a wide range of diseases.” Read the press release here: https://lnkd.in/eDCiZPQN
-
-
This #RareDiseaseDay, we at Be Bio are reminded of our mission– to develop transformative medicines for people living with, or impacted by rare diseases. With our eyes locked on the patient, we are proud to do our part in transforming patient care. #BeBio #BCells
-
-
Today, we honor the strength, unity, and resilience that define our nation—values that inspire progress and guide us forward. Happy Presidents' Day from the BeBio team! #BeBio #PresidentsDay
-
-
At Be Bio, we recognize diversity as a catalyst for innovation, creativity, and growth. This Black History Month–and every day, we honor the contributions of Black leaders, innovators, and pioneers who have shaped healthcare. By championing diverse voices and perspectives, we remain committed to creating a future where healthcare is inclusive, equitable, and accessible for all. #BeBio #BlackHistoryMonth
-
-
We’re excited to announce the publication of our manuscript in the journal Molecular Therapy titled, “In vivo tracking of ex vivo generated 89Zr-oxine labeled plasma cells by PET in a non-human primate model,” highlighting first-of-its-kind preclinical research from a collaboration study showing homing and engraftment of ex-vivo-generated plasma cells in non-human primates (NHPs) with intact immune systems. Read the manuscript here: https://lnkd.in/eQezBxh7
-
-
Do you have expertise in cGMP, GCP, GLP, and global regulatory requirements? We’re looking for a Quality Assurance Senior Director to join our team. Take part in leading the development of our Quality Management Systems, driving compliance, and ensuring top standards in clinical and manufacturing operations. Join us in advancing innovative therapies for patients in need. Tap the link for additional details and application link: https://lnkd.in/ei9F4yxH
-
-
We’re hiring! Join Be Bio as our Sr. Engineer, Process Development, where you’ll optimize cell therapy processes, analyze data, and foster continuous improvement through scientific leadership and innovative solutions. Help shape the future of Medicine with us– apply here: https://lnkd.in/e4jiPEq7
-